FDA 483 data is just the tip of the iceberg
AboutBlogFDA EmployeeOver 40,000+ FDA inspection documents: 483s, EIRs, 483Rs
inspectorprofile icon

Paul Bellamy InspectorProfile

$995 - Available for instant download

This FDA InspectorProfile is a report of relevant audit-related information on Paul Bellamy, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Human Drugs.

Product Description

This InspectorProfile report is updated through and lists Paul Bellamy's inspections in 27 countries: United States, Canada, Finland, Netherlands, Germany, United Kingdom, Malta & Gozo, Denmark, Italy, France, Spain, India, China, Japan, Jordan, Israel, Korea (the Republic of), Australia, Singapore, Philippines, Austria, Mexico, Taiwan (Province of China), Taiwan, Poland, Norway, and Portugal.

FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Paul Bellamy's inspection information so that you can mitigate investigator-related risks.

Example Report

Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Paul Bellamy.

FDA InspectorProfile Overview Example
FDA InspectorProfile Metrics Example
FDA InspectorProfile Citations Example
FDA InspectorProfile Inspections List

Product details

  • Paul Bellamy's metrics:
    • 483 issue rate, total inspections, total 483s
    • Most common citations (based on CFR), CFR description, and citation frequency
    • Total inspections, total 483s
    • Longest / shortest inspection in duration - all time, last year
    • Total warning letters
  • Inspection details for each inspection (since 2000) Paul Bellamy has conducted including:

Note: The EIR and 483 documents are sold separately.